Literature DB >> 23946298

Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.

Martin R Turner1, Raph Goldacre, Sreeram Ramagopalan, Kevin Talbot, Michael J Goldacre.   

Abstract

OBJECTIVE: To study whether the risk of amyotrophic lateral sclerosis (ALS) is increased in people with prior autoimmune disease.
METHODS: An all-England hospital record-linkage dataset spanning 1999-2011 was used. Cohorts were constructed of people with each of a range of autoimmune diseases; the incidence of ALS in each disease cohort was compared with the incidence of ALS in a cohort of individuals without prior admission for the autoimmune disease.
RESULTS: There were significantly more cases than expected of ALS associated with a prior diagnosis of asthma, celiac disease, younger-onset diabetes (younger than 30 years), multiple sclerosis, myasthenia gravis, myxedema, polymyositis, Sjögren syndrome, systemic lupus erythematosus, and ulcerative colitis.
CONCLUSIONS: Autoimmune disease associations with ALS raise the possibility of shared genetic or environmental risk factors.

Entities:  

Mesh:

Year:  2013        PMID: 23946298      PMCID: PMC3795611          DOI: 10.1212/WNL.0b013e3182a6cc13

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?

Authors:  Masoud Etemadifar; Seyed-Hossein Abtahi; Mojtaba Akbari; Amir-Hadi Maghzi
Journal:  Mult Scler       Date:  2011-12-06       Impact factor: 6.312

2.  Premorbid weight, body mass, and varsity athletics in ALS.

Authors:  N Scarmeas; T Shih; Y Stern; R Ottman; L P Rowland
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

3.  Lifetime physical activity and the risk of amyotrophic lateral sclerosis.

Authors:  Mark H B Huisman; Meinie Seelen; Sonja W de Jong; Kirsten R I S Dorresteijn; Perry T C van Doormaal; Anneke J van der Kooi; Marianne de Visser; Helenius Jurgen Schelhaas; Leonard H van den Berg; Jan Herman Veldink
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-16       Impact factor: 10.154

4.  TDP-43 frontotemporal lobar degeneration and autoimmune disease.

Authors:  Zachary A Miller; Katherine P Rankin; Neill R Graff-Radford; Leonel T Takada; Virginia E Sturm; Clare M Cleveland; Lindsey A Criswell; Philipp A Jaeger; Trisha Stan; Kristin A Heggeli; Sandy Chan Hsu; Anna Karydas; Baber K Khan; Lea T Grinberg; Maria Luisa Gorno-Tempini; Adam L Boxer; Howard J Rosen; Joel H Kramer; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; William W Seeley; Tony Wyss-Coray; Bruce L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-30       Impact factor: 10.154

5.  Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis.

Authors:  S Körner; K Kollewe; J Ilsemann; A Müller-Heine; R Dengler; K Krampfl; S Petri
Journal:  Eur J Neurol       Date:  2012-10-25       Impact factor: 6.089

Review 6.  Evidence for autoimmunity in amyotrophic lateral sclerosis.

Authors:  S H Appel; R G Smith; J I Engelhardt; E Stefani
Journal:  J Neurol Sci       Date:  1993-09       Impact factor: 3.181

7.  A case of celiac disease mimicking amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Gurjit Chohan; Gerardine Quaghebeur; Richard C D Greenhall; Marios Hadjivassiliou; Kevin Talbot
Journal:  Nat Clin Pract Neurol       Date:  2007-10

8.  Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.

Authors:  S H Appel; J I Engelhardt; J S Henkel; L Siklos; D R Beers; A A Yen; E P Simpson; Y Luo; G Carrum; H E Heslop; M K Brenner; U Popat
Journal:  Neurology       Date:  2008-10-21       Impact factor: 9.910

9.  Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members.

Authors:  Elisabeth A Cats; Anne Suzanne Bertens; Jan H Veldink; Leonard H van den Berg; W Ludo van der Pol
Journal:  J Neurol       Date:  2011-11-23       Impact factor: 4.849

10.  Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort.

Authors:  Valentina Gallo; Petra A Wark; Mazda Jenab; Neil Pearce; Carol Brayne; Roel Vermeulen; Peter M Andersen; Goran Hallmans; Andreas Kyrozis; Nicola Vanacore; Mariam Vahdaninia; Verena Grote; Rudolf Kaaks; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Ruth C Travis; Jesper Petersson; Oskar Hansson; Larraitz Arriola; Juan-Manuel Jimenez-Martin; Anne Tjønneland; Jytte Halkjær; Claudia Agnoli; Carlotta Sacerdote; Catalina Bonet; Antonia Trichopoulou; Diana Gavrila; Kim Overvad; Elisabete Weiderpass; Domenico Palli; J Ramón Quirós; Rosario Tumino; Kay-Tee Khaw; Nicholas Wareham; Aurelio Barricante-Gurrea; Veronika Fedirko; Pietro Ferrari; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Heiner Boeing; Matthaeus Vigl; Lefkos Middleton; Elio Riboli; Paolo Vineis
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

View more
  63 in total

1.  Motor neuron disease: Are diabetes and amyotrophic lateral sclerosis related?

Authors:  Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2015-08-18       Impact factor: 42.937

2.  Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.

Authors:  Larry Lam; Ramesh C Halder; Dennis J Montoya; Liudmilla Rubbi; Arturo Rinaldi; Bien Sagong; Sarah Weitzman; Rachel Rubattino; Ram Raj Singh; Matteo Pellegrini; Milan Fiala
Journal:  Am J Neurodegener Dis       Date:  2015-12-28

3.  Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.

Authors:  Cassie S Mitchell; Sabrina K Hollinger; Shivani D Goswami; Meraida A Polak; Robert H Lee; Jonathan D Glass
Journal:  Neurodegener Dis       Date:  2015-02-20       Impact factor: 2.977

4.  The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis.

Authors:  Yingying Zhang; Aaron Burberry; Jin-Yuan Wang; Jackson Sandoe; Sulagna Ghosh; Namrata D Udeshi; Tanya Svinkina; Daniel A Mordes; Joanie Mok; Maura Charlton; Quan-Zhen Li; Steven A Carr; Kevin Eggan
Journal:  Genes Dev       Date:  2018-06-27       Impact factor: 11.361

Review 5.  Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

Authors:  Deepti Lall; Robert H Baloh
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

6.  Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ran S Rotem; Ryan M Seals; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

7.  Ptosis and bulbar onset: an unusual phenotype of familial ALS?

Authors:  Fabiola De Marchi; L Corrado; E Bersano; M F Sarnelli; V Solara; S D'Alfonso; R Cantello; L Mazzini
Journal:  Neurol Sci       Date:  2017-11-13       Impact factor: 3.307

8.  Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease.

Authors:  Aaron Burberry; Naoki Suzuki; Jin-Yuan Wang; Rob Moccia; Daniel A Mordes; Morag H Stewart; Satomi Suzuki-Uematsu; Sulagna Ghosh; Ajay Singh; Florian T Merkle; Kathryn Koszka; Quan-Zhen Li; Leonard Zon; Derrick J Rossi; Jennifer J Trowbridge; Luigi D Notarangelo; Kevin Eggan
Journal:  Sci Transl Med       Date:  2016-07-13       Impact factor: 17.956

9.  Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients.

Authors:  Larry Lam; Lydia Chin; Ramesh C Halder; Bien Sagong; Sam Famenini; James Sayre; Dennis Montoya; Liudmilla Rubbi; Matteo Pellegrini; Milan Fiala
Journal:  FASEB J       Date:  2016-07-01       Impact factor: 5.191

10.  Prior medical conditions and the risk of amyotrophic lateral sclerosis.

Authors:  Meinie Seelen; Perry T C van Doormaal; Anne E Visser; Mark H B Huisman; Margot H J Roozekrans; Sonja W de Jong; Anneke J van der Kooi; Marianne de Visser; Nicol C Voermans; Jan H Veldink; Leonard H van den Berg
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.